Your browser doesn't support javascript.
loading
Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
Phelan, Rachel; Im, Annie; Hunter, Rebecca L; Inamoto, Yoshihiro; Lupo-Stanghellini, Maria Teresa; Rovo, Alicia; Badawy, Sherif M; Burns, Linda; Eissa, Hesham; Murthy, Hemant S; Prasad, Pinki; Sharma, Akshay; Suelzer, Elizabeth; Agrawal, Vaibhav; Aljurf, Mahmoud; Baker, Karen; Basak, Grzegorz W; Buchbinder, David; DeFilipp, Zachariah; Grkovic, Lana Desnica; Dias, Ajoy; Einsele, Hermann; Eisenberg, Michael L; Epperla, Narendranath; Farhadfar, Nosha; Flatau, Arthur; Gale, Robert Peter; Greinix, Hildegard; Hamilton, Betty K; Hashmi, Shahrukh; Hematti, Peiman; Jamani, Kareem; Maharaj, Dipnarine; Murray, John; Naik, Seema; Nathan, Sunita; Pavletic, Steven; Peric, Zinaida; Pulanic, Drazen; Ross, Richard; Salonia, Andrea; Sanchez-Ortega, Isabel; Savani, Bipin N; Schechter, Tal; Shah, Ami J; Smith, Stephanie M; Snowden, John A; Steinberg, Amir; Tremblay, Douglas; Vij, Sarah C.
Afiliación
  • Phelan R; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. rphelan@mcw.edu.
  • Im A; Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA. rphelan@mcw.edu.
  • Hunter RL; University of Pittsburgh/UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Inamoto Y; Division of Hematology, University of Colorado Anschutz Medical Center, Aurora, CO, USA.
  • Lupo-Stanghellini MT; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Rovo A; Hematology and Bone Marrow Transplantation Unit, IRCC San Raffaele Scientific Institute, Milano, Italy.
  • Badawy SM; Department of Hematology and Central Hematology Laboratory, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland.
  • Burns L; Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
  • Eissa H; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Murthy HS; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Prasad P; Department of Pediatrics, Center for Cancer and Blood Disorders, University of Colorado School of Medicine, Aurora, CO, USA.
  • Sharma A; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.
  • Suelzer E; Louisiana State University Health Sciences Center/Children's Hospital of New Orleans, Department of Pediatrics, New Orleans, LA, USA.
  • Agrawal V; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Aljurf M; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Baker K; Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA.
  • Basak GW; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • Buchbinder D; Duke University Medical Center, Durham, NC, USA.
  • DeFilipp Z; University Clinical Centre, Medical University of Warsaw, Warsaw, Poland.
  • Grkovic LD; Division of Pediatric Hematology, Children's Hospital of Orange County, Orange, CA, USA.
  • Dias A; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA, USA.
  • Einsele H; University Hospital Centre Zagreb, Zagreb, Croatia.
  • Eisenberg ML; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Epperla N; Universitätsklinikum Würzburg, Department of Internal Medicine II, Würzburg, Germany.
  • Farhadfar N; Department of Urology, Stanford University School of Medicine, Stanford, CA, USA.
  • Flatau A; Division of Hematology, Department of Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Gale RP; Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, FL, USA.
  • Greinix H; Association of Cancer Online Resources, Association of Cancer Online Resources, Austin, TX, USA.
  • Hamilton BK; Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • Hashmi S; Medical University Graz, Division of Hematology, Graz, Austria.
  • Hematti P; Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Jamani K; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Maharaj D; Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, UAE.
  • Murray J; Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin, Madison, WI, USA.
  • Naik S; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.
  • Nathan S; South Florida Bone Marrow Stem Cell Transplant Institute, Boynton Beach, FL, USA.
  • Pavletic S; The Christie NHS Foundation Trust, Manchester, UK.
  • Peric Z; Division Hematology and Oncology, Department of Medicine, Penn State Cancer Institute, Milton Hershey Medical Center, Hershey, PA, USA.
  • Pulanic D; Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL, USA.
  • Ross R; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Salonia A; University Hospital Centre Zagreb and Medical School University of Zagreb, Zagreb, Croatia.
  • Sanchez-Ortega I; University Hospital Centre Zagreb and Medical School University of Zagreb, Zagreb, Croatia.
  • Savani BN; The University of Sheffield, Sheffield, UK.
  • Schechter T; University Vita-Salute San Raffaele, Milan, Italy.
  • Shah AJ; Division of Experimental Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy.
  • Smith SM; Institut Catala d'Oncologia, Barcelona, Spain.
  • Snowden JA; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Steinberg A; Division of Pediatric Hematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
  • Tremblay D; Division of Hematology/ Oncology/ Stem Cell Transplantation and Regenerative Medicine, Lucile Packard Children's Hospital, Stanford School of Medicine, Palo Alto, CA, USA.
  • Vij SC; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Bone Marrow Transplant ; 57(7): 1150-1163, 2022 07.
Article en En | MEDLINE | ID: mdl-35523848
Male-specific late effects after hematopoietic cell transplantation (HCT) include genital chronic graft-versus-host disease (GvHD), hypogonadism, sexual dysfunction, infertility, and subsequent malignancies. They may be closely intertwined and cause prolonged morbidity and decreased quality of life after HCT. We provide a systematic review of male-specific late effects in a collaboration between transplant physicians, endocrinologists, urologists, dermatologists, and sexual health professionals through the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research, and the Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. The systematic review summarizes incidence, risk factors, screening, prevention and treatment of these complications and provides consensus evidence-based recommendations for clinical practice and future research.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies / Systematic_reviews Límite: Adult / Humans / Male Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies / Systematic_reviews Límite: Adult / Humans / Male Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos